BTAI
Bioxcel Therapeutics·NASDAQ
--
--(--)
--
--(--)
Latest data update time: Updated on 2026-01-31
Latest data update time: Updated on 2026-01-31
3.54 / 10Overall Score
NeturalInvestment Rating
3.54 / 10Overall Score
NeturalInvestment Rating
Is BTAI a Buy, Sell, or Hold?
- Based on a composite score of 3.54/10, we rate BTAI as a Netural. Our analysis breaks down into 3.23/10 for Fundamentals, 2.19/10 for Technicals, and 4.37/10 for Sentiment, indicating the stock is likely to consolidate sideways.
What is the current technical signals for BTAI?
Is BTAI fundamentally strong?
What is the analyst consensus for BTAI?
Is BTAI a Buy, Sell, or Hold?
- Based on a composite score of 3.54/10, we rate BTAI as a Netural. Our analysis breaks down into 3.23/10 for Fundamentals, 2.19/10 for Technicals, and 4.37/10 for Sentiment, indicating the stock is likely to consolidate sideways.
Is BTAI fundamentally strong?
What is the current technical signals for BTAI?
What is the analyst consensus for BTAI?
